This randomized , double-blind , placebo-controlled , crossover study evaluated @ days of once daily , topical intranasal SB-@ @ mg in @ patients with NAR using a CDA challenge experimental model in an environmental exposure chamber ( EEC , Cetero Research , Mississauga , Ontario ) .